Shining a Light on Rare Nerve Tumors

New findings published in Science Signaling suggest that targeting mechanical signals between cells may become a fresh approach to fighting cancer. The concept flows from discovering a network of proteins that appear to interact with a protein called Merlin when people have the rare disease neurofibromatosis 2 (NF2).